Authorizing a manufacturer of an investigational drug, biological product, or device to make available the investigational drug, biological product, or device to eligible patients; specifying the manner in which a specified drug, product, or device may be provided to eligible patients; prohibiting a health occupations board from taking specified action against a health care provider's license on a specified basis; establishing that the Act does not create a specified cause of action; etc.
Bill File Type: Pre-Filed
Effective Date(s): October 1, 2016
|Date Posted||Document Name|
|12/17/2015||Text - First - Investigational Drugs, Biological Products, and Devices - Right to Try Act|
|3/16/2016||Vote - Senate - Committee - Finance|
( 21-2B-01 through 21-2B-07 )
Last Updated: 2/3/2020 2:29 PM